HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibitors of topoisomerase II delay progress through mitosis and induce a doubling of the DNA content in CHO cells.

Abstract
The effect of inhibition of topoisomerase II on chromosome segregation in CHO cells has been studied using cytogenetical techniques and measurements of nuclear DNA content. Cells were accumulated in metaphase, and their passages into the subsequent stages of mitosis, and into interphase, were examined. Of the compounds tested, five (Amsacrine, Etoposide, Hoechst 33342, Mitoxantrone, and nalidixic acid) greatly reduce the rate at which the chromosomes pass from metaphase through anaphase to the subsequent interphase and induce a high proportion of nuclei which contain a 4C amount of DNA. In several cases, the reformation of membranes around chromosomes can be seen although the chromosomes remain in a condition similar to metaphase, with the chromatids linked at the centromeres. Two other inhibitors of topoisomerase II, Hoechst 33258 and Merbarone, failed to delay cells in metaphase and did not induce tetraploidy. This failure may well be due to an inability of the compounds to penetrate the cells sufficiently quickly, or at a high enough concentration. Overall, the results are consistent with the hypothesis that topoisomerase II is essential for the segregation of chromosomes in mammals and other eukaryotes.
AuthorsA T Sumner
JournalExperimental cell research (Exp Cell Res) Vol. 217 Issue 2 Pg. 440-7 (Apr 1995) ISSN: 0014-4827 [Print] United States
PMID7698244 (Publication Type: Journal Article)
Chemical References
  • Topoisomerase II Inhibitors
  • DNA
  • DNA Topoisomerases, Type II
Topics
  • Animals
  • CHO Cells
  • Chromosomes (physiology)
  • Cricetinae
  • DNA (biosynthesis)
  • DNA Topoisomerases, Type II (metabolism)
  • Mitosis (drug effects)
  • Topoisomerase II Inhibitors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: